Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Calithera Biosciences
343 Oyster Point Blvd., Suite 200
South San Francisco, CA 94080
Phone: 650-870-1000
http://www.calithera.com/

Calithera is discovering and developing novel small molecule oncology therapeutics that inhibit pathways critical to tumor growth and survival. The Calithera team has the experience and the ability needed to discover novel therapeutics and advance these discoveries through clinical development. The company is applying this expertise to build a pipeline of anti-cancer compounds that are distinct from other oncology therapeutics. Calithera's lead clinical candidate, CB-839, blocks glutaminase, an enzyme critical to tumor metabolism, and is poised to enter Phase 1 clinical testing.

Key Contact
NameTitleE-Mail
Susan MolineauxCEOsmolineaux@calithera.com


Funding Events
DateAmountTypeInvestors
10/29/13$35,000,000Series D Adage Capital Partners
Advanced Technology Ventures
Delphi Ventures
Longwood Fund
Morgenthaler
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.